Know Your Rights
Your rights when your health plan denies coverage
Your appeal options and deadlines depend on your health plan and the type of denial. Federal rules now require certain plans to publish prior authorization statistics for medical items and services, excluding drugs. Here is what those reporting rules cover and how to check the process for your own request.
CMS-0057-F covers Medicare Advantage, state Medicaid and CHIP programs, covered Medicaid and CHIP managed care plans, and certain qualified health plans on federally facilitated Marketplaces. Its prior authorization reporting and process requirements exclude drugs, including drugs covered under medical benefits. They do not give you medication-specific denial rates or set one appeal deadline for every plan.
What's changing
March 31, 2026
Covered plans and programs were required to post their first public prior authorization reports on their own websites by March 31, 2026, using calendar year 2025 data. The reports cover non-drug items and services and include aggregate approval and denial percentages, approval-after-appeal data, and decision times.
Beginning in 2027: Electronic prior authorization
Covered plans generally must support electronic prior authorization requests and responses for non-drug items and services. Start dates depend on the program and plan period, and some exceptions apply. These requirements do not guarantee an immediate decision.
What this means for you
If your plan is covered by the reporting rule, look for its prior authorization report on its public website. Check the reporting year, plan or program, and how each measure is defined. These reports can help you understand patterns, but differences in patients, services and counting methods limit comparisons. They do not predict whether your own request will be approved.
What the data already shows
Prior authorization requests decided by Medicare Advantage plans in 2024
Of those requests were fully or partially denied
Of denials were never appealed (only 11.5% were)
Of appealed denials were overturned
Your rights as a patient
Check your appeal options
Your denial notice should explain the reason for the decision and how to request a review. Your options and filing deadlines depend on your plan and the type of denial. Keep the notice and check its instructions before the deadline.
Ask for the reason behind a denial
For a covered non-drug prior authorization request, CMS-0057-F requires the plan to give your provider a specific reason for denial. This requirement applies regardless of how the request was submitted. Your own denial notice and appeal instructions follow the rules for your plan.
You can ask about urgent review
If waiting could seriously harm your health or your ability to regain function, ask your plan or prescriber about urgent review. The deadline depends on your plan, whether you are requesting coverage or appealing a denial, and the review level. Check your denial notice for the filing deadline and instructions for requesting faster review.
Independent review may be available
Depending on your plan and the reason for denial, you may be able to request an independent external review. Eligibility and the steps you must complete first vary. Medicare and Medicaid use their own review processes. Check your denial notice and plan documents for the process that applies to you.
If you have Medicare Part D
Your plan generally must decide an initial drug-coverage request within 72 hours, or 24 hours if accepted for urgent review. For a first plan appeal about drug coverage, the decision is generally due within seven calendar days after receipt, or 72 hours if accepted for urgent review. Your plan must act sooner when your health requires. Payment requests and later appeal stages follow different rules.
Your doctor is your best advocate
A peer-to-peer call between your prescribing doctor and the insurer's medical director is often the fastest path to overturning a denial. Ask your doctor's office to request one.
State-specific PA protections
Your state may have rules on prior authorization, step therapy or continuity of care. Which protections apply depends on your plan, treatment and the law's effective date. Check your state insurance department and plan documents for the rules that apply to you.
Find your state's PA protections →Already treated but now denied?
Retroactive denials happen when your insurer refuses to pay after you've already received treatment. You have rights, and steps you can take to fight back.
Learn what to do →Biosimilar switches: the new PA battleground
In 2025-2026, dozens of biosimilars are launching for major drugs like Stelara, Humira, and Eylea. Insurers are moving fast to switch patients to lower-cost alternatives. While biosimilars are safe and effective, non-medical switching: forcing a switch when you're stable on your current medication, is something you can fight.
Ellen decodes what they don't want you to understand
Prior authorization is designed to be confusing. Ellen translates denial codes, maps step therapy ladders, finds clinical shortcuts, and generates appeals, all in simple terms.
Sources: CMS-0057-F final rule, published February 8, 2024; CMS prior authorization FAQs, updated October 14, 2026; Medicare Part D decision and appeal timeframes at 42 CFR 423.568, 423.572, and 423.590; KFF Medicare Advantage prior authorization analysis (2024 data: medical services in Medicare Advantage, not Part D drugs); OIG Medicare Advantage denial reports. Ellen provides general information, not medical or legal advice.